The provided text primarily discusses Pepkor Holdings, a retail company, and is not relevant to the pharmaceutical sector. It mentions that analyst consensus for Pepkor's price target has decreased, indicating lowered confidence in its fair value. The text also confusingly references a sector ETF report for a pharmaceutical fund, but no actual news, performance data, or analyst opinions specific to that pharmaceutical fund or its holdings are presented. There is no substantive information to analyze regarding the pharmaceutical industry or the fund in question.